Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006

被引:291
|
作者
Cronin-Fenton, D. P. [1 ]
Sondergaard, F. [1 ]
Pedersen, L. A. [1 ]
Fryzek, J. P. [2 ]
Cetin, K. [2 ]
Acquavella, J. [2 ]
Baron, J. A. [3 ,4 ]
Sorensen, H. T. [1 ]
机构
[1] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8200 Aarhus N, Denmark
[2] Amgen Inc, Dept Epidemiol, Thousand Oaks, CA USA
[3] Dartmouth Hitchcock Med Ctr, Dept Community & Family Med, Lebanon, NH 03766 USA
[4] Dartmouth Hitchcock Med Ctr, Dept Med, Lebanon, NH 03766 USA
关键词
incidence rate; venous thromboembolism; epidemiology; treatment; RISK-FACTORS; THROMBOSIS; EPIDEMIOLOGY; REGISTRATION; THALIDOMIDE; DISEASE;
D O I
10.1038/sj.bjc.6605883
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Venous thromboembolism (VTE) frequently complicates cancer. Data on tumour-specific VTE predictors are limited, but may inform strategies to prevent thrombosis. METHODS: We computed incidence rates (IRs) with 95% confidence intervals (CIs) for VTE hospitalisation in a cohort of cancer patients (n = 57 591) and in a comparison general-population cohort (n = 287 476) in Denmark. The subjects entered the study in 1997-2005, and the follow-up continued through 2006. Using Cox proportional-hazards regression, we estimated relative risks (RRs) for VTE predictors, while adjusting for comorbidity. RESULTS: Throughout the follow-up, VTE IR was higher among the cancer patients (IR = 8.0, 95% CI = 7.6-8.5) than the general population (IR = 4.7, 95% CI = 4.3-5.1), particularly in the first year after cancer diagnosis (IR = 15.0, 95% CI = 13.8-16.2, vs IR = 8.6, 95% CI = 7.6-9.9). Incidence rates of VTE were highest in patients with pancreas (IR = 40.9, 95% CI = 29.5-56.7), brain (IR = 17.7, 95% CI = 11.3-27.8) or liver (IR = 20.4, 95% CI = 9.2-45.3) tumours, multiple myeloma (IR = 22.6, 95% CI = 15.4-33.2) and among patients with advanced-stage cancers (IR = 27.7, 95% CI = 24.0-32.0) or those who received chemotherapy or no/symptomatic treatment. The adjusted RR (aRR) for VTE was highest among patients with pancreas (aRR = 16.3, 95% CI = 8.1-32.6) or brain cancer (aRR = 19.8 95% CI = 7.1-55.2), multiple myeloma (aRR = 46.1, 95% CI = 13.1-162.0) and among patients receiving chemotherapy, either alone (aRR = 18.5, 95% CI = 11.9-28.7) or in combination treatments (aRR = 16.2, 95% CI = 12.0-21.7). CONCLUSIONS: Risk of VTE is higher among cancer patients than in the general population. Predictors of VTE include recency of cancer diagnosis, cancer site, stage and the type of cancer-directed treatment. British Journal of Cancer (2010) 103, 947-953. doi:10.1038/sj.bjc.6605883 www.bjcancer.com Published online 14 September 2010 (C) 2010 Cancer Research UK
引用
收藏
页码:947 / 953
页数:7
相关论文
共 50 条
  • [31] Risk of venous thromboembolism in men with prostate cancer compared with men in the general population: a nationwide population-based cohort study in Sweden
    Balabanova, Yanina
    Farahmand, Bahman
    Garmo, Hans
    Stattin, Par
    Brobert, Gunnar
    BMJ OPEN, 2022, 12 (05): : e055485
  • [32] Venous Thromboembolism and Cancer Population-Based Incidence Study
    不详
    GEFASSCHIRURGIE, 2013, 18 (08): : 680 - 680
  • [33] Venous thromboembolism and risk of depression: a population-based cohort study
    Jorgensen, Helle
    Horvath-Puho, Erzsebet
    Laugesen, Kristina
    Braekkan, Sigrid K.
    Hansen, John-Bjarne
    Sorensen, Henrik Toft
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2023, 21 (04) : 953 - 962
  • [34] Proteinuria and venous thromboembolism in pregnancy: a population-based cohort study
    Akbari, Ayub
    Kunkel, Elizabeth
    Bota, Sarah E.
    Harel, Ziv
    Le Gal, Gregoire
    Cox, Conor
    Hundemer, Gregory L.
    Canney, Mark
    Clark, Edward
    Massicotte-Azarniouch, David
    Eddeen, Anan Bader
    Knoll, Greg
    Sood, Manish M.
    CLINICAL KIDNEY JOURNAL, 2021, 14 (09) : 2101 - 2107
  • [35] Cancer risk in patients with migraine: A population-based cohort study in Denmark
    Elser, Holly
    Skajaa, Nils
    Ehrenstein, Vera
    Fuglsang, Cecilia Hvitfeldt
    Farkas, Dora Kormendine
    Sorensen, Henrik Toft
    HEADACHE, 2022, 62 (01): : 57 - 64
  • [36] Risk of Cholecystitis in Patients With Cancer A Population-based Cohort Study in Denmark
    Thomsen, Reimar W.
    Thomsen, Henrik F.
    Norgaard, Mette
    Cetin, Karynsa
    McLaughlin, Joseph K.
    Tarone, Robert E.
    Fryzek, Jon R.
    Sorensen, Henrik T.
    CANCER, 2008, 113 (12) : 3410 - 3419
  • [37] Risk of venous thromboembolism in patients with total hip/knee replacements and matched controls: A population-based cohort study in Denmark
    Lalmohamed, A.
    Vestergaard, P.
    Pouwels, S.
    Klop, C.
    de Boer, A.
    de Vries, F.
    BONE, 2012, 50 : S186 - S186
  • [38] RISK OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH TOTAL HIP/KNEE REPLACEMENTS AND MATCHED CONTROLS: A POPULATION-BASED COHORT STUDY IN DENMARK
    Lalmohamed, Arief
    Vestergaard, Peter
    Klop, Corinne
    Bazelier, Marloes
    de Boer, Anthonius
    de Vries, Frank
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S557 - S558
  • [39] The risk of cholecystitis in patients with cancer and the general population in a population-based cohort study in Western Denmark, 1995-2003
    Fryzek, J. P.
    Thomsen, R. W.
    Thomsen, H. F.
    Norgaard, M.
    Cetin, K.
    McLaughlin, J. K.
    Tarone, R. E.
    Sorensen, H. T.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [40] Arterial Thromboembolism in Cancer Patients A Danish Population-Based Cohort Study
    Mulder, Frits, I
    Horvath-Puho, Erzsebet
    van Es, Nick
    Pedersen, Lars
    Buller, Harry R.
    Botker, Hans Erik
    Sorensen, Henrik T.
    JACC: CARDIOONCOLOGY, 2021, 3 (02): : 205 - 218